Plain-English translation of NCT05962177 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a long-term study that follows people with relapsing-remitting multiple sclerosis who are on different treatment levels. Researchers want to compare how well newer, more powerful MS medications work compared to standard treatments by carefully tracking brain changes and disease markers over time using MRI scans and blood tests.
While newer, stronger MS medications have been shown to work better in short-term studies, doctors need long-term evidence from real patients to confirm they truly prevent disease progression better than standard treatments. This study also wants to understand other factors beyond the medication itself—like sleep problems or other conditions—that might affect how the disease progresses.
You likely qualify if…
You likely don't qualify if…
You would visit the study center at Montpellier University Hospital for regular appointments where you'll have MRI brain scans and blood tests taken to monitor how your MS is progressing. The study compares three groups: people on standard MS medications, people on newer, stronger medications, and untreated patients. Your participation would continue long-term so researchers can track changes in your brain and blood markers over time.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
France